Outcome comparison of different approaches to aortic root aneurysm.


Journal

Kardiologia polska
ISSN: 1897-4279
Titre abrégé: Kardiol Pol
Pays: Poland
ID NLM: 0376352

Informations de publication

Date de publication:
2022
Historique:
received: 13 02 2022
accepted: 13 02 2022
pubmed: 14 2 2022
medline: 4 5 2022
entrez: 13 2 2022
Statut: ppublish

Résumé

The treatment of aortic root aneurysm remains challenging for both cardiac surgeons and cardiologists. This study aimed to assess and compare the long-term outcomes of different approaches to aortic root replacement (ARR). All elective patients operated for aortic root aneurysm with or without aortic regurgitation at our institution over a 10-year period were included. We excluded patients with any degree of aortic stenosis and with active endocarditis. We assessed mortality, freedom from reoperation, freedom from aortic valve regurgitation, and the rate of hemorrhagic and thromboembolic complications. Two hundred and four patients underwent elective aortic root replacement: 107 (53%) valve-sparing aortic root replacement (VSARR), 35 (17%) mechanical Bentall procedure (MB), and 62 (30%) Bio-Bentall procedure (BB). Early mortality for VSARR, BB, and MB group was 2.8%, 4.8%, and 0%, respectively (P = 0.40). Estimated 5-year survival was: 90.2% vs. 78.4% vs. 94.2%, respectively (P = 0.12), 5-year freedom from reoperation: 97.8%, 96.6%, and 96.8%, respectively (P = 0.99). Estimat-ed 5-year freedom from complications was: 94.2%, 83.1% and 57.3% in the VSARR, BB and MB group, respectively (P <0.001). On last follow-up echocardiography, 90.5%, 98.4%, and 97.1% (P = 0.08) of patients were free from aortic regurgitation grade 2 or higher. The median (IQR) aortic valve peak gradient was 9 (6-12) mm Hg, 12 (10-18) mm Hg and 16 (14-22) mm Hg, respectively (P <0.001). Complications were predicted by mechanical Bentall (hazard ratio, 6.70 [2.54-17.63]; P <0.001). With the same mortality, freedom from reoperation, and a minimal late complication rate in comparison with mechanical Bentall and Bio-Bentall, VSARR might be the preferred approach to aortic root aneurysm.

Sections du résumé

BACKGROUND
The treatment of aortic root aneurysm remains challenging for both cardiac surgeons and cardiologists.
AIMS
This study aimed to assess and compare the long-term outcomes of different approaches to aortic root replacement (ARR).
METHODS
All elective patients operated for aortic root aneurysm with or without aortic regurgitation at our institution over a 10-year period were included. We excluded patients with any degree of aortic stenosis and with active endocarditis. We assessed mortality, freedom from reoperation, freedom from aortic valve regurgitation, and the rate of hemorrhagic and thromboembolic complications.
RESULTS
Two hundred and four patients underwent elective aortic root replacement: 107 (53%) valve-sparing aortic root replacement (VSARR), 35 (17%) mechanical Bentall procedure (MB), and 62 (30%) Bio-Bentall procedure (BB). Early mortality for VSARR, BB, and MB group was 2.8%, 4.8%, and 0%, respectively (P = 0.40). Estimated 5-year survival was: 90.2% vs. 78.4% vs. 94.2%, respectively (P = 0.12), 5-year freedom from reoperation: 97.8%, 96.6%, and 96.8%, respectively (P = 0.99). Estimat-ed 5-year freedom from complications was: 94.2%, 83.1% and 57.3% in the VSARR, BB and MB group, respectively (P <0.001). On last follow-up echocardiography, 90.5%, 98.4%, and 97.1% (P = 0.08) of patients were free from aortic regurgitation grade 2 or higher. The median (IQR) aortic valve peak gradient was 9 (6-12) mm Hg, 12 (10-18) mm Hg and 16 (14-22) mm Hg, respectively (P <0.001). Complications were predicted by mechanical Bentall (hazard ratio, 6.70 [2.54-17.63]; P <0.001).
CONCLUSION
With the same mortality, freedom from reoperation, and a minimal late complication rate in comparison with mechanical Bentall and Bio-Bentall, VSARR might be the preferred approach to aortic root aneurysm.

Identifiants

pubmed: 35152397
pii: VM/OJS/J/88526
doi: 10.33963/KP.a2022.0045
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

436-444

Auteurs

Radosław Gocoł (R)

Department of Cardiac Surgery, Upper-Silesian Heart Center, Katowice, Poland. mdeja@sum.edu.pl.

Jarosław Bis (J)

Department of Cardiac Surgery, Upper-Silesian Heart Center, Katowice, Poland.
Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland.

Marcin Malinowski (M)

Department of Cardiac Surgery, Upper-Silesian Heart Center, Katowice, Poland.
Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland.

Łukasz Morkisz (Ł)

Department of Cardiac Surgery, Upper-Silesian Heart Center, Katowice, Poland.

Mikołaj Jodłowski (M)

Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland.

Tomasz Darocha (T)

Department of Anesthesiology and Intensive Care, Medical University of Silesia, Poland.

Joanna Ciosek (J)

3rd Division of Cardiology and Structural Heart Diseases, Upper-Silesian Heart Center, Katowice, Poland.

Wojciech Wojakowski (W)

3rd Division of Cardiology and Structural Heart Diseases, Upper-Silesian Heart Center, Katowice, Poland.

Marek A Deja (MA)

Department of Cardiac Surgery, Upper-Silesian Heart Center, Katowice, Poland.
Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH